Meng Li 李濛

Health Economics Professor | Biotech Analyst

[CEVR @TuftsCEVR]

Calling all health economists! The Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year Contest is back! Submit your CEA for a chance to win $500. Deadline: January 31, 2024. Don't miss out!

Learn more & apply: https://t.co/HYFudQGAwu #HEOR #CEA

[Peter Neumann @PeterNeumann11]

The outlook for US payer coverage of specialty drugs in 2005.

Register here for our webinar, Dec 4, 3-3:30 ET: https://t.co/td7omRloxz

@jchambers241 @mollytoba @npcnow @brianreid #heor #biosimilars @TuftsCEVR

[Peter Neumann @PeterNeumann11]

The final agenda for the 10/26 symposium in Boston, "Celebrating CEA," is now available.

Panelists include: @Basucally, @contirena1, Emond, Garrison, Lakdawalla, Phelps, Weinstein, etc.

Register in person or online:
https://t.co/XaDi6ztmB0 @TuftsCEVR @DukeMargolis @socmdm

[CEVR @TuftsCEVR]

We are thrilled to announce that pioneering #CEA researcher Milton C. Weinstein has joined Panel 2 at the 10/26 Tufts-CEVR / Duke Margolis symposium.

Register now!

In person: https://t.co/X09ZYozhFR

Webinar: https://t.co/WsaGPFDEVY

[Meng Li 李濛 @drmengli]

Furthermore, low- and middle-income countries will need to strengthen their regulatory and reimbursement processes to ensure timely access to new medicines for their populations.

@TuftsCEVR

[Meng Li 李濛 @drmengli]

Numerous breakthrough cancer medicines have emerged in recent years, yet availability remains limited outside a few major, high-income markets. Our latest research in @GlobalHealthBMJ revealed growing disparity worldwide 👇🏼

https://t.co/LqHBlBbUSH

[Meng Li 李濛 @drmengli]

For this to work, high-income countries like the US will need to resist the urge to reference prices from other countries, which neither reflects the value of American patients nor incentivize innovation.

[Peter Neumann @PeterNeumann11]

We are pleased to announce that @brianreid, a nationally-recognized expert in prescription drug policy and communications, has joined @TuftsCEVR as a Senior Fellow.

More here: https://t.co/FX9nLdwHUg #heor

[CEVR @TuftsCEVR]

What is/will be the role of #CEA in public policy? Hear from @sarahkemond, @contirena1, @ProfLouGarrison, Steven Kymes, and @laprosser during Panel 4 at 10/26 Tufts-CEVR / Duke Margolis event.

Register now:

In-Person: https://t.co/X09ZYoyJQj

Webinar: https://t.co/WsaGPFD76q

[Peter Neumann @PeterNeumann11]

The latest in cost-effectiveness analyses...

It will be a great discussion at this panel at the upcoming Boston symposium on Oct 26.

Register:
In person: https://t.co/csekiRQidi
Virtual: https://t.co/zZMmoG3pz7
@Basucally @mel_whittington @socmdm @CHEyork

[CEVR @TuftsCEVR]

Eager to learn about new #CEA methods from leading scientists? Join Anirban Basu, Darius Lakdawalla, Melanie Whittington, and Beth Woods for Panel 3 at 10/26 Tufts-CEVR / Duke Margolis Symposium.

Register now:

In Person: https://t.co/X09ZYoyJQj
Webinar: https://t.co/WsaGPFD76q

[Peter Neumann @PeterNeumann11]

One month from today in Boston, the special symposium on cost-effectiveness analysis.

Panel 2 of 5 panels is featured below. @socmdm.

Join us!

[CEVR @TuftsCEVR]

The 2nd panel at 10/26 Tufts-CEVR / Duke Margolis symposium will feature reflections on CEA from three luminaries: @AnkurFactorial, Marthe Gold, and Charles Phelps.

Register now:

In Person: https://t.co/L5gA6C35ch
Webinar: https://t.co/WsaGPFDEVY

[CEVR @TuftsCEVR]

Excited to announce speakers for first of 5 panels at 10/26 Tufts-CEVR/Duke Margolis celebration of #CEA in Boston: Scott Cantor, Patty Synnott, and @drmengli. Stay tuned for more!

Register:

In-person: https://t.co/L5gA6C35ch
Webinar: https://t.co/WsaGPFDEVY

@MooreFound #HEOR

[Peter Neumann @PeterNeumann11]

Looking forward to speaking Sept 25 in DC on Medicare's coverage with evidence development program at this event @USC Capital Campus.

Co-hosted by @SchaefferCenter @SUBiodesign & @TuftsCEVR

Info here: https://t.co/Qh4hX5529J @CMSGov #Medicare

[Peter Neumann @PeterNeumann11]

Join us! Special symposium on cost-effectiveness analysis in Boston, Oct 26 before @socmdm.

Confirmed speakers: @Basucally @Conti @sarahkemond @AnkurFactorial @mel_whittington @WrightCensored, Garrison, Gold, Lakdawalla, Phelps, Woods, etc.
https://t.co/QRocRMk76U @TuftsCEVR

[CEVR @TuftsCEVR]

Join our team!

We're hiring a Post-doc fellow, sponsored by @GSK, to study the economics of vaccination/infectious disease, learn advanced methods in HEOR and decision science.

Apply today! Applicants considered on rolling basis: https://t.co/dhLDldLtmn.

#HEOR #postdoc #hiring

[CEVR @TuftsCEVR]

In today’s @Health_Affairs Forefront, CEVR’s @adelealexandr, @jchambers241, and Genentech’s Stacey Kowal argue Medicare drug price negotiations should consider non-clinical benefits to patients/families as part of unmet need.

#IRA #Pharma

https://t.co/Uq2ynHl0Qz